ESBL-Producing and Non-ESBL-Producing Escherichia coli Isolates from Urinary Tract Differ in Clonal Distribution, Virulence Gene Content and Phylogenetic Group

References

• Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653–660. doi:10.1038/nrurol.2010.190
   PubMed Web of Science ®Google Scholar
• Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284. doi:10.1038/nrmicro3432
   PubMed Web of Science ®Google Scholar
• Mazzariol A, Bazaj A, Cornaglia G. Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review. J Chemother. 2017;29(sup1):2–9. doi:10.1080/1120009X.2017.1380395
   PubMed Web of Science ®Google Scholar
• Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad Med. 2020;132(3):234–250. doi:10.1080/00325481.2019.1680052
   PubMed Web of Science ®Google Scholar
• McDanel J, Schweizer M, Crabb V, et al. Incidence of Extended-Spectrum β-Lactamase (ESBL)-producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review. Infect Contr Hospital Epidemiol. 2017;38(10):1209–1215. doi:10.1017/ice.2017.156
   PubMed Web of Science ®Google Scholar
• Tansarli GS, Poulikakos P, Kapaskelis A, Falagas ME. Proportion of extended-spectrum beta-lactamase (ESBL)-producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence--systematic review. J Antimicrob Chemother. 2014;69(5):1177–1184. doi:10.1093/jac/dkt500
   PubMed Web of Science ®Google Scholar
• Yamasaki S, Le TD, Vien MQ, Van Dang C, Yamamoto Y. Prevalence of extended-spectrum β-lactamase-producing Escherichia coli and residual antimicrobials in the environment in Vietnam. Anim Health Res Rev. 2017;18(2):128–135. doi:10.1017/S1466252317000160
   PubMed Web of Science ®Google Scholar
• Hayajneh WA, Hajj A, Hulliel F, et al. Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013. Int J Infect Dis. 2015;35:56–61. doi:10.1016/j.ijid.2015.04.011
   PubMed Web of Science ®Google Scholar
• Al-Jamei SA, Albsoul AY, Bakri FG, Al-Bakri AG. Extended-spectrum β-lactamase producing E. coli in urinary tract infections: a two-center, cross-sectional study of prevalence, genotypes and risk factors in Amman, Jordan. J Infect Public Health. 2019;12(1):21–25. doi:10.1016/j.jiph.2018.07.011
   PubMed Web of Science ®Google Scholar
• Jia P, Zhu Y, Li X, et al. High prevalence of extended-spectrum beta-lactamases in Escherichia coli strains collected from strictly defined community-acquired urinary tract infections in adults in China: a multicenter prospective clinical microbiological and molecular study. Front Microbiol. 2021;12:663033. doi:10.3389/fmicb.2021.663033
   PubMed Web of Science ®Google Scholar
• Pilmis B, Parize P, Zahar JR, Lortholary O. Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae. Eur J Clin Microbiol Infect Dis. 2014;33(8):1263–1265. doi:10.1007/s10096-014-2094-y
   PubMed Web of Science ®Google Scholar
• Liu X, Cui D, Li H, et al. Direct medical burden of antimicrobial-resistant healthcare-associated infections: empirical evidence from China. J Hosp Infect. 2020;105(2):295–305. doi:10.1016/j.jhin.2020.01.003
   PubMed Web of Science ®Google Scholar
• Huttner A, Hatz C, van den Dobbelsteen G, et al. Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial. Lancet Infect Dis. 2017;17(5):528–537. doi:10.1016/S1473-3099(17)30108-1
   PubMed Web of Science ®Google Scholar
• Yun KW, Kim DS, Kim W, Lim IS. Molecular typing of uropathogenic Escherichia coli isolated from Korean children with urinary tract infection. Korean J Pediatr. 2015;58(1):20–27. doi:10.3345/kjp.2015.58.1.20
   PubMedGoogle Scholar
• Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol. 2005;43(12):5860–5864. doi:10.1128/JCM.43.12.5860-5864.2005
   PubMed Web of Science ®Google Scholar
• Mathers AJ, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015;28(3):565–591. doi:10.1128/CMR.00116-14
   PubMed Web of Science ®Google Scholar
• Hertz FB, Nielsen JB, Schønning K, et al. ”Population structure of drug-susceptible,-resistant and ESBL-producing Escherichia coli from community-acquired urinary tract”. BMC Microbiol. 2016;16:63. doi:10.1186/s12866-016-0681-z
   PubMed Web of Science ®Google Scholar
• Manges AR, Geum HM, Guo A, Edens TJ, Fibke CD, Pitout JDD. Global extraintestinal pathogenic Escherichia coli (ExPEC) lineages. Clin Microbiol Rev. 2019;32(3). doi:10.1128/CMR.00135-18
   PubMed Web of Science ®Google Scholar
• Choi HJ, Jeong SH, Shin KS, et al. Characteristics of Escherichia coli urine isolates and risk factors for secondary bloodstream infections in patients with urinary tract infections. Microbiol Spectr. 2022;10(4):e0166022. doi:10.1128/spectrum.01660-22
   PubMed Web of Science ®Google Scholar
• Jafari A, Falahatkar S, Delpasand K, Sabati H, Sedigh Ebrahim-Saraie H. Emergence of Escherichia coli ST131 causing urinary tract infection in western Asia: a systematic review and meta-analysis. Microb Drug Resist. 2020;26(11):1357–1364. doi:10.1089/mdr.2019.0312
   PubMed Web of Science ®Google Scholar
• Xiao S, Tang C, Zeng Q, et al. Antimicrobial resistance and molecular epidemiology of Escherichia coli from bloodstream infection in Shanghai, China, 2016–2019. Front Med. 2022;8. doi:10.3389/fmed.2021.803837
   Web of Science ®Google Scholar
• Fukushima Y, Sato T, Tsukamoto N, et al. Clonal/subclonal changes and accumulation of CTX-M-type β-lactamase genes in fluoroquinolone-resistant Escherichia coli ST131 and ST1193 strains isolated during the past 12 years, Japan. J Global Antimicrob Resist. 2021;27:150–155. doi:10.1016/j.jgar.2021.08.015
   PubMed Web of Science ®Google Scholar
• Birgy A, Madhi F, Jung C, et al. Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017. J Antimicrob Chemother. 2020;75(1):96–105. doi:10.1093/jac/dkz423
   PubMed Web of Science ®Google Scholar
• Kallonen T, Brodrick HJ, Harris SR, et al. Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131. Genome Res. 2017;27(8):1437–1449. doi:10.1101/gr.216606.116
   PubMed Web of Science ®Google Scholar
• Horcajada JP, Soto S, Gajewski A, et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol. 2005;43(6):2962–2964. doi:10.1128/JCM.43.6.2962-2964.2005
   PubMed Web of Science ®Google Scholar
• Moreno E, Prats G, Sabaté M, Pérez T, Johnson JR, Andreu A. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother. 2006;57(2):204–211. doi:10.1093/jac/dki468
   PubMed Web of Science ®Google Scholar
• Matsukawa M, Igarashi M, Watanabe H, et al. Epidemiology and genotypic characterisation of dissemination patterns of uropathogenic Escherichia coli in a community. Epidemiol Infect. 2019;147:e148. doi:10.1017/S0950268819000426
   PubMed Web of Science ®Google Scholar
• Lee JH, Subhadra B, Son YJ, et al. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Lett Appl Microbiol. 2016;62(1):84–90. doi:10.1111/lam.12517
   PubMed Web of Science ®Google Scholar
• Dadi BR, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia. BMC Infect Dis. 2020;20(1):108. doi:10.1186/s12879-020-4844-z
   PubMed Web of Science ®Google Scholar
• Paniagua-Contreras GL, Monroy-Pérez E, Rodríguez-Moctezuma JR, Domínguez-Trejo P, Vaca-Paniagua F, Vaca S. Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico. J Microbiol Immunol Infect. 2017;50(4):478–485. doi:10.1016/j.jmii.2015.08.005
   PubMedGoogle Scholar
• Stoppe NC, Silva JS, Carlos C, et al. Worldwide Phylogenetic Group Patterns of Escherichia coli from commensal human and wastewater treatment plant isolates. Front Microbiol. 2017;8:2512. doi:10.3389/fmicb.2017.02512
   PubMed Web of Science ®Google Scholar
• Duriez P, Clermont O, Bonacorsi S, et al. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology. 2001;147(Pt 6):1671–1676. doi:10.1099/00221287-147-6-1671
   PubMedGoogle Scholar
• Khairy RM, Mohamed ES, Abdel Ghany HM, Abdelrahim SS. Phylogenic classification and virulence genes profiles of uropathogenic E. coli and diarrhegenic E. coli strains isolated from community acquired infections. PLoS One. 2019;14(9):e0222441. doi:10.1371/journal.pone.0222441
   PubMed Web of Science ®Google Scholar
• Grude N, Potaturkina-Nesterova NI, Jenkins A, et al. A comparison of phylogenetic group, virulence factors and antibiotic resistance in Russian and Norwegian isolates of Escherichia coli from urinary tract infection. Clin Microbiol Infect. 2007;13(2):208–211. doi:10.1111/j.1469-0691.2006.01584.x
   PubMed Web of Science ®Google Scholar
• Ramos NL, Dzung DT, Stopsack K, et al. Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries. Eur J Clin Microbiol Infect Dis. 2011;30(12):1587–1593. doi:10.1007/s10096-011-1264-4
   PubMed Web of Science ®Google Scholar
• Derakhshandeh A, Firouzi R, Motamedifar M, et al. Virulence characteristics and antibiotic resistance patterns among various phylogenetic groups of uropathogenic Escherichia coli isolates. Jpn J Infect Dis. 2015;68(5):428–431. doi:10.7883/yoken.JJID.2014.327
   PubMed Web of Science ®Google Scholar
• Moreno E, Andreu A, Pérez T, Sabaté M, Johnson JR, Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect. 2006;134(5):1015–1023. doi:10.1017/S0950268806005917
   PubMed Web of Science ®Google Scholar
• Ejrnæs K, Stegger M, Reisner A, et al. Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation. Virulence. 2011;2(6):528–537. doi:10.4161/viru.2.6.18189
   PubMed Web of Science ®Google Scholar
• Bashir S, Haque A, Sarwar Y, Ali A, Anwar MI. Virulence profile of different phylogenetic groups of locally isolated community acquired uropathogenic E. coli from Faisalabad region of Pakistan. Ann Clin Microbiol Antimicrob. 2012;11:23. doi:10.1186/1476-0711-11-23
   PubMed Web of Science ®Google Scholar
• Kot B, Wicha J, Grużewska A, Piechota M, Wolska K, Obrębska M. Virulence factors, biofilm-forming ability, and antimicrobial resistance of urinary Escherichia coli strains isolated from hospitalized patients. Turkish J Med Sci. 2016;46(6):1908–1914. doi:10.3906/sag-1508-105
   PubMed Web of Science ®Google Scholar